SCOPUS 정보 검색 플랫폼

Annals of Hematology

Volumn 82, Issue 4, 2003, Pages 262-

On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma [2]

(2) Ribatti, D a Vacca, A a

a UNIVERSITY OF BARI MEDICAL SCHOOL (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; THALIDOMIDE;

ANGIOGENESIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; MEDICAL RESEARCH; MICROVASCULATURE; MULTIPLE MYELOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 0038180612 PISSN: 09395555 EISSN: None Source Type: Journal
DOI: 10.1007/s00277-003-0622-4 Document Type: Letter

Times cited : (1)

References (5)

1
- 0037134709
- Clinical applications of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us
- Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical applications of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94:883-893
- (2002) J. Natl. Cancer Inst. , vol.94 , pp. 883-893
- Hlatky, L.¹ Hahnfeldt, P.² Folkman, J.³

2
- 0032887340
- Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
- Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, Trent JM, Meltzer PS, Hendrix MJC (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752
- (1999) Am. J. Pathol. , vol.155 , pp. 739-752
- Maniotis, A.J.¹ Folberg, R.² Hess, A.³ Seftor, E.A.⁴ Gardner, L.M.G.⁵ Pe'er, J.⁶ Trent, J.M.⁷ Meltzer, P.S.⁸ Hendrix, M.J.C.⁹

3
- 0030722076
- Non-small-lung carcinoma tumor growth without morphological evidence of neo-angiogenesis
- Pezzella, F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter KC, Harris AL, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F (1997) Non-small-lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151:1417-1423
- (1997) Am. J. Pathol. , vol.151 , pp. 1417-1423
- Pezzella, F.¹ Pastorino, U.² Tagliabue, E.³ Andreola, S.⁴ Sozzi, G.⁵ Gasparini, G.⁶ Menard, S.⁷ Gatter, K.C.⁸ Harris, A.L.⁹ Fox, S.¹⁰ Buyse, M.¹¹ Pilotti, S.¹² Pierotti, M.¹³ Rilke, F.¹⁴

4
- 0036215946
- Is thalidomide a true anti-angiogenic molecule in multiple myeloma?
- Ribatti D, Vacca A (2002) Is thalidomide a true anti-angiogenic molecule in multiple myeloma? Haematologica 87:344-345
- (2002) Haematologica , vol.87 , pp. 344-345
- Ribatti, D.¹ Vacca, A.²

5
- 0032748385
- Antitumor activity of thalidomide in refractory multiple myeloma
- Singhal S, Metha J, Desikan R, Ayers D, Robertson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565-1571
- (1999) N. Engl. J. Med. , vol.341 , pp. 1565-1571
- Singhal, S.¹ Metha, J.² Desikan, R.³ Ayers, D.⁴ Robertson, P.⁵ Eddlemon, P.⁶ Munshi, N.⁷ Anaissie, E.⁸ Wilson, C.⁹ Dhodapkar, M.¹⁰ Zeddis, J.¹¹ Barlogie, B.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.